Speciality Medicines (BOM:544738) Inventories, Raw Materials & Components: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544738 Speciality Medicines Ltd BOM:544738
21 GF Score
Price ₹156.65
! 3 Warning Signs
View Full Analysis

What is Speciality Medicines Inventories, Raw Materials & Components?

Speciality Medicines BOM:544738 -6.76% 21 Inventories, Raw Materials & Components is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544738 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Speciality Medicines's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Speciality Medicines Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Speciality Medicines's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Speciality Medicines Inventories, Raw Materials & Components Chart

Speciality Medicines Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00 0.00

Speciality Medicines Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components 0.00 0.00 0.00 0.00 0.00
BOM:544738
21GF Score
Speciality Medicines Ltd BOM:544738
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Speciality Medicines Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0.0 Mil mean?
Speciality Medicines (BOM:544738) has a Inventories, Raw Materials & Components of ₹0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Speciality Medicines and its competitors.
Is Speciality Medicines' Inventories, Raw Materials & Components too high?
Speciality Medicines' current Inventories, Raw Materials & Components is ₹0.0 Mil. Overall, Speciality Medicines has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Speciality Medicines' Inventories, Raw Materials & Components compare to ZTS?
Speciality Medicines' Inventories, Raw Materials & Components of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Speciality Medicines and its competitors. Speciality Medicines's current Inventories, Raw Materials & Components is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speciality Medicines stock overvalued right now?
Speciality Medicines (BOM:544738) has a current Inventories, Raw Materials & Components of ₹0.0 Mil. The current Inventories, Raw Materials & Components is ₹0.0 Mil. Speciality Medicines' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Speciality Medicines (BOM:544738), the current Inventories, Raw Materials & Components is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Speciality Medicines Business Description

Address 20 Mahakali Caves Road, Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, Andheri (East, Mumbai, MH, IND, 400093
Speciality Medicines Ltd is engaged in the marketing and distribution of finished formulations of specialty pharmaceutical products, comprising oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its product range includes various dosage forms such as tablets, capsules, syrups, injections, infusions, inhalers, sprays, and topical formulations. The company operates through two business models: (a) Manufacturing, through contract manufacturing basis, and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers. The majority of the company's revenue is derived from the sale of its projects, mainly through exports to other countries.
21GF Score

Get the complete analysis for BOM:544738

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹156.65
Price